Home › Funds › Verdad Advisers, LP › WHWK
Verdad Advisers, LP position in WHWK
WHITEHAWK THERAPEUTICS INC · Health Care
Verdad Advisers, LP reported holding 301,483 shares of WHWK (WHITEHAWK THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.4M, representing 1.32% of its reported portfolio and ranking #13 among its reported holdings. Verdad Advisers, LP has disclosed WHWK holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Verdad Advisers, LP's WHWK position evolved
Verdad Advisers, LP first disclosed a stake in WHWK in Q1 2026 at 115,484 shares (US$398K). The position peaked in Q2 2026 at 301,483 shares, worth US$1.4M. Across 2 filings, Verdad Advisers, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 301,483 shares valued at US$1.4M — an increase of 185,999 shares quarter over quarter.. Notable position changes include a 161% increase in Q2 2026 (shares fell 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 115.48K | $398.42K | New |
| Q2 2026 | 301.48K | $1.38M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About WHWK and 13F data
WHWK (WHITEHAWK THERAPEUTICS INC) is a Health Care company. 48 other funds we track also report a position in WHWK — the largest reported positions include Yu Fan (US$22.3M), ACUTA CAPITAL PARTNERS, LLC (US$21.5M), QVT Financial LP (US$21.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding WHWK
- Yu Fan 4.86M sh · $22.26M · Q2 2026
- ACUTA CAPITAL PARTNERS, LLC 4.69M sh · $21.46M · Q2 2026
- QVT Financial LP 4.62M sh · $21.14M · Q2 2026
- MONTANOVA CAPITAL, LLC 4.30M sh · $19.69M · Q2 2026
- Avoro Capital Advisors LLC 2.85M sh · $13.05M · Q2 2026
- KVP Capital Advisors, LP 2.17M sh · $9.92M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 1.14M sh · $5.22M · Q2 2026
- STEMPOINT CAPITAL LP 1.02M sh · $4.68M · Q2 2026
- Ally Bridge Group (NY) LLC 817.94K sh · $3.75M · Q2 2026
More on Verdad Advisers, LP
FAQ
How long has Verdad Advisers, LP held WHWK?
Verdad Advisers, LP has disclosed WHWK holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Verdad Advisers, LP's current position in WHWK?
As of Q2 2026, Verdad Advisers, LP holds 301.48K shares of WHWK (WHITEHAWK THERAPEUTICS INC), valued at $1.38M, representing 1.32% of its reported portfolio and ranking #13.
Has Verdad Advisers, LP been buying or selling WHWK?
In the latest 13F filing (Q2 2026), Verdad Advisers, LP increased its position in WHWK. The position peaked in Q2 2026 at 301.48K shares.
Which other funds hold WHWK?
Other major institutional holders of WHWK include Yu Fan, ACUTA CAPITAL PARTNERS, LLC, QVT Financial LP, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.